Traditionally, the histologic diagnosis of antibodymediated rejection has been suggested based on peritubular capillary inflammation, thrombosis, fibrinoid necrosis, and demonstration of immunoglobulin and complement deposits in allograft tissue. [1] [2] [3] In recent years, the spectrum of pathologic changes associated with antibody-mediated rejection has expanded considerably. It is now well recognized that light microscopic findings can be quite subtle even in the presence of circulating donor-specific antibodies. [4] [5] [6] The conventional immunofluorescence panel of immunoglobulin and complement components has been replaced by the detection of C4d, a single complement degradation product that can independently predict unfavorable graft outcome. [7] [8] [9] [10] [11] [12] [13] [14] C4d participates in the classic pathway of complement activation. Activated C4 is cleaved to C4a and C4b. C4b binds to an amino or hydroxyl group and is then converted to C4d, which can covalently bind with peritubular capillary basement membrane. 15 Initial immunohistochemical methods for C4d utilized a monoclonal antibody and fresh frozen sections, which are not always available. In recent years, several medical centers have started using a polyclonal antibody that can be used to stain formalin-fixed paraffin-embedded tissue. Limited data are available on the comparative sensitivity of these two methods. Nadasady et al and Regele et al found formalin-fixed tissue to give acceptable results, 16, 17 whereas Seemayer et al 18 indicated that formalin fixation had a detrimental effect on C4d detection. Most published articles on C4d immunohistochemistry have focused on peritubular capillary staining. The significance of glomerular basement membrane and tubular basement membrane staining is not yet well established. Sijpkens et al 19 described an association between glomerular basement membrane staining and chronic transplant glomerulopathy. Bracamonte et al 20 and Hever et al 21 demonstrated tubular basement membrane deposits in association with BK virus nephropathy. We present our own experience with C4d immunohistochemistry in both fresh frozen and formalin-fixed paraffin-embedded tissues. Staining patterns of different anatomic locations were correlated with clinical and histologic parameters including the presence of circulating donor-specific antibodies. C4d staining was scored in a semiquantitative manner and correlated with histologic scores of chronic transplant glomerulopathy, tubular atrophy, arteriolar hyalinosis and arterial thickening using Banff criteria for renal allograft pathology.
Materials and Methods

Case Selection
Biopsies were selected based on availability of both frozen and paraffin sections for analysis. The routine practice in our medical center is to submit only formalin-fixed tissue. However, physicians do freeze a portion of the biopsy in selected cases, if there is clinical concern for antibody-mediated rejection.
C4d Staining
Paired frozen and formalin-fixed tissue C4d stains were performed on 52 kidney biopsies from 51 renal transplant recipients. Immunostaining in formalinfixed paraffin-embedded tissue was performed using rabbit anti-human C4d polyclonal antibody (Alpco Diagnostics, Windham, NH, USA). Briefly, 4 mm sections of allograft kidney were deparaffinized, placed in a pressure cooker for 20 min and sequentially incubated at 371C with TRIS-EDTA (pH 8.5), 1:50 dilution of primary antibody for 44 min, 1:100 dilution of a biotinylated anti-rabbit secondary antibody for 8 min, streptavidin-alkaline phosphate conjugate for 8 min, Fast red A-naphthol for 8 min, Fast red B for 8 min and a routine hematoxylin counterstain. All reagents were components of the Ventana Enhanced Alkaline Phosphatase Red Detection Kit (catalog no. 760-031; Ventana Medical Systems, Tucson, AZ, USA) and used according to the enclosed instructions. The frozen tissue staining procedure used a mouse monoclonal antibody directed against human C4d (Biogenesis, Kingston, NH, USA). Briefly, 6-8 mm frozen sections were obtained, dried at room temperature, fixed in cold acetone for 10 min and then placed into a 371C incubator overnight. Morphosave bisulfate fixative (10 Â ) was used to help retain morphologic detail of friable tissue. The subsequent procedure was similar to paraffin-embedded staining except that the Alpco antibody was replaced by a 1:100 dilution of the Biogenesis antibody (32 min incubation at 371C).
Interpretation of C4d Stain
Evaluation of C4d staining was done primarily by the first author (IB), however, selected cases were jointly reviewed with the principal author (PR). Different anatomic compartments in the kidney were analyzed in both frozen and paraffin-embedded samples as follows:
(1) Linear or finely granular peritubular capillary staining was classified as diffuse when it was seen in more than 50% of microscopic fields available for evaluation. It was referred to as focal when present in 10-50% of biopsied tissue, and negative if the staining did not even reach that threshold. Areas with tubular atrophy were excluded from analysis. These criteria are in agreement with recommendations made in the 2007 Banff Conference. (2) Glomerular basement membrane staining was evaluated according to the most intensely stained glomerulus. It was further classified as global, segmental and minimal when more than 50, 10-50 or less than 10% of glomerular capillaries were stained, respectively. It was considered negative when no glomerular basement membrane staining was observed. (3) Tubular basement membrane staining was evaluated only within the cortex, as medullary tubules can be difficult to distinguish from the vasa recta by routine light microscopy. In individual tubules, staining was considered to be present if more than half of the tubular basement membrane circumference was stained. Staining was further characterized as diffuse, focal and negative when 450, 10-50 and less than 10% of the tubules showed C4d deposits, respectively. (4) Arteriolar staining was classified as diffuse, focal or negative, when 450, 10-50 or o10% of arterioles showed C4d deposits, respectively. Similar criteria were used for arterial staining evaluation. However, when only one artery was available for evaluation, the designations diffuse and focal reflected the percent of circumferential area of that vessel showing C4d deposits.
For each anatomic compartment, the total number of positive specimens was also determined by disregarding the actual pattern of staining. To facilitate
Significance of the distribution of C4d deposits I Batal et al comparison, C4d was graded on a semiquantitative scale (0-2) in the peritubular capillary, tubular basement membranes, arteriolar and arterial compartments of each biopsy. These scores corresponded to negative, focal and diffuse staining, respectively. For staining in the glomerular basement membrane, a four-point scale (0-3) was assigned corresponding to negative, minimal, segmental or global staining, respectively.
Histologic Evaluation
Standard H&E, PAS, silver and trichrome sections were evaluated according to Banff 97 criteria 1 as follows: chronic transplant glomerulopathy was scored according to the percentage of peripheral capillary loops showing double contour in the most severely affected glomerulus (cg0, cg1, cg2 and cg3). Tubular atrophy was graded as ct0, ct1, ct2 and ct3 according to the percentage of atrophic tubules in sampled cortical area. Arteriolar hyalinosis was scored according to the severity of PAS-positive hyaline thickness (ah0, ah1, ah2 and ah3). Chronic vascular thickening was graded according to the percentage of vascular narrowing in the most affected artery (cv0, cv1, cv2 and cv3). Histologic evaluation was performed on paraffin-embedded tissue biopsies as freezing artifacts make it difficult to evaluate chronic transplant glomerulopathy, tubular atrophy and arteriolar hyalinosis on frozen sections. Our analysis, therefore, assumes that the severity of histologic lesions as assessed on paraffinembedded tissue is applicable to the whole kidney (including the portion of this biopsy taken for frozen section C4d staining).
Circulating Donor-Specific Antibodies
Blood samples were collected on the day of transplantation and at multiple times after transplant. Serum/plasma specimens were tested by enzyme-linked immunosorbent assay (ELISA). We used commercial LAT-Mt and LAT-1288t ELISA kits (One Lambda, Canoga Park, CA, USA), in accord with the manufacturer's instructions to identify IgG anti-HLA class I and class II specific alloantibodies. Both IgG anti-HLA class I and class II specific antibodies were measured indirectly by a second enzyme-linked colorimetric reaction. The assay was read at 630 nm using an ELISA reader (ELX 800; BioTek, Winooski, Vermont, USA, and computer software from One Lambda). All tests were run in duplicate and the results of ELISA screen were expressed as a percent of the average positive serum control. Donor-specific antibodies were defined as antibodies directed against one or more donor HLA type. Positive donor-specific antibodies were detected in serum samples corresponding to 14/44 (32%) of these specimens. All positive circulating donor-specific antibodies were detected within 8 days of the biopsy except in two cases, one of them was performed 16 days before biopsy, whereas the other was positive 160 days before biopsy, following which it became negative, possibly due to allograft absorbance. 22 Clinical and pathologic parameters were obtained by retrospective blinded chart review in accordance with methods approved by the University of Pittsburgh Institutional Review Board (IRB protocol no. 602112).
Statistics
Rank sum tests (Kruskal-Wallis one-way analysis of variance on ranks and Mann-Whitney rank sum test) were used to compare C4d semiquantitative scores and staining patterns in different anatomic components. These statistical analyzes were performed using SigmaStat 2.0.3 software (SPSS Inc., Chicago, IL, USA). The ability of peritubular capillary staining to detect circulating donor-specific antibodies was evaluated using contingency tables and a w 2 -test (P-value expressed as Fisher's exact test). This statistical analysis was performed using Statistica (software from Statsoft, Tulsa, OK, USA, 1995). 23 P-values less than 0.05 were considered statistically significant.
Results
There were 52 kidney allograft specimens from 51 patients (29 men, 22 women) ranging in age between 19 and 81 years (mean 53±15 years). The race of the patients was as follows: Caucasians (n ¼ 36), African Americans (n ¼ 9), American Indian (n ¼ 1) and others or not available (n ¼ 5). The sources of allografts were deceased donor (n ¼ 30), living related donor (n ¼ 13), living unrelated donor (n ¼ 6) and not available (n ¼ 2). The primary diseases that led to renal failure and transplantation were diabetic mellitus (n ¼ 11), hypertension
, undetermined (n ¼ 1) and not available (n ¼ 6). The percentage of biopsies with detectable C4d staining together with C4d scores is presented in Table 1 . Mean C4d scores for tubular basement membranes and arterioles were significantly higher in frozen compared with paraffinembedded biopsies. C4d staining intensity in all other compartments also tended be higher in frozen sections than paraffin-embedded samples, but the differences were not statistically significantly (Table 1) .
A description of C4d staining patterns in individual anatomic compartments follows.
Peritubular Capillary Staining
Within peritubular capillaries, the frequency of positive staining was somewhat higher in frozen compared to paraffin-embedded biopsies (56 vs 44%). Diffuse peritubular capillary C4d deposits had a tendency to be more common in frozen specimens (43 vs 19%) whereas focal staining was observed somewhat more frequently in paraffinembedded biopsies (25% paraffin embedded vs 14% frozen) (Table 1) . Overall, there was a trend toward a higher C4d staining scores in frozen (1.0 ± 0.9) compared with paraffin-embedded biopsies (0.6±0.8) (P ¼ 0.086).
Information regarding contemporaneous circulating donor-specific antibody was available for 44/52 allograft kidney biopsies from 43 patients ( Table 2) . For frozen biopsies obtained from patients with a history of circulating donor-specific antibodies (n ¼ 14), diffuse C4d peritubular capillary staining was seen in 11/14 (79%) (MHC type II (n ¼ 8), MHC type I (n ¼ 3)), whereas focal and negative staining were found in 1/14 (7%) (MHC type II (n ¼ 1)) and 2/14 (14%) (MHC type I (n ¼ 1), both types (n ¼ 1)) biopsies, respectively. Within paraffin-embedded specimens obtained from the same patients, diffuse staining was present in 5/14 (36%) (MHC type II (n ¼ 4), MHC type I (n ¼ 1)), whereas focal and negative staining were present in 6/14 (43%) (MHC type II (n ¼ 3), MHC type I (n ¼ 2), both types (n ¼ 1)) and 3/14 (21%) (MHC type II (n ¼ 2), MHC type I (n ¼ 1)) biopsies, respectively. Thus, in frozen biopsies, diffuse peritubular capillary staining was associated more often with the presence of circulating donor-specific antibodies compared to focally and negatively stained biopsies (diffuse vs negative, P ¼ 0.0005; diffuse vs focal, P ¼ 0.02). The frequency of donor-specific antibodies in focal vs negative C4d stained biopsies did not reach statistical significance in this small data set. In contrast to frozen specimens, focal staining in paraffin-embedded biopsies ( Figure 1 ) seemed to be associated with donor-specific antibodies as frequently as diffuse staining (diffuse vs negative staining, P ¼ 0.003; focal vs negative 0.002; diffuse vs focal, no significant difference). Combining diffuse 5/14 (36%) and focal 6/14 (43%) staining in paraffin-embedded biopsies allowed documentation of peritubular capillary deposits in 11/14 (79%) biopsies with donor-specific antibodies (Table 2 ). This latter frequency was similar to that attained by diffuse Circulating donor-specific antibodies were absent in 6/17 (35%) of frozen specimens with diffuse peritubular capillary staining and 6/7 (86%) of specimens with focal staining. In paraffin-embedded samples, absence of circulating donorspecific antibodies was noted in 3/8 (38%) and 4/10 (40%) of samples with diffuse and focal peritubular capillary staining, respectively. To evaluate the clinical significance of this apparently high rate of false-positive C4d stains, we separately analyzed patients with diffuse C4d and the presence (group A, n ¼ 11), or absence (group B, n ¼ 6) of circulating donor-specific antibodies. Group A patients had an inferior outcome comparable to group B patients. Specifically, 6/11 patients within group A developed graft failure due to chronic allograft nephropathy (n ¼ 5) or refractory rejection (n ¼ 1), whereas 3/6 patients within group B developed graft failure due to chronic allograft nephropathy (n ¼ 2) and recurrent IgA nephropathy (n ¼ 1). There was a trend toward earlier detection of diffuse C4d staining in group A compared to group B (458±723 vs 2190 ± 2486 days after transplantation). The onset of graft failure following first detection of diffuse C4d was more rapid in group A (80±81 vs 276±102 days, P ¼ 0.03). The length of clinical follow-up was not significantly different between these two groups (413±467 days group A vs 307±86 days group B).
Glomerular Basement Membrane
In frozen tissue, glomeruli were available in 39 biopsies (Table 1 ). C4d staining pattern was global in 46%, segmental in 5%, minimal in 5% and negative in 44% of samples. In 48 of paraffin-embedded specimens with glomeruli available for evaluation, the staining pattern was similar, with global, segmental, minimal and negative staining found in 25, 12, 19 and 44%, respectively. Glomerular basement membrane C4d score in frozen and paraffinembedded groups (1.5 ± 1.5 frozen vs 1.2 ± 1.3 paraffin embedded) was also not significantly different. To assess a potential relationship between transplant glomerulopathy and C4d deposition, we assigned cg scores to paraffin-embedded biopsies whereas different patterns of C4d deposition in the glomerular basement membranes were evaluated in both frozen and permanent samples (Table 3 ). In paraffin-embedded biopsies, the mean cg score for all biopsies with C4d deposits was higher than the corresponding score for C4d-negative biopsies (1.5±0.8 vs 1.1±0.8, P ¼ 0.03; Figure 2 ). In frozen tissue, this difference did not reach statistical significance (1.6 ± 0.8 vs 1.1 ± 0.8, P ¼ 0.1). In paraffin-embedded biopsies with positive glomerular membrane staining, cg scores tended to be the highest with a global staining pattern (1.7 ± 0.8), and the lowest in biopsies with minimal staining (1.3±0.9). This relationship was less obvious in frozen sectioned specimens. All four biopsies with severe chronic transplant glomerulopathy (grade cg3) showed C4d deposits within the glomerular Biopsies with GBM deposits in FS (n ¼ 39)
Biopsies with GBM deposits in PE a (n ¼ 48)
FS, frozen section; PE, paraffin embedded; GBM, glomerular basement membrane; cg, chronic transplant glomerulopathy score. For C4d assessment, intact glomeruli in well-preserved areas were available in 48 paraffin-embedded specimens and in 39 frozen specimens. Scores for cg were assessed on silver stained paraffin-embedded sections only.
Significance of the distribution of C4d deposits I Batal et al basement membranes in both frozen specimens (global (n ¼ 3) and minimal (n ¼ 1)) and paraffinembedded specimens (global (n ¼ 2), segmental (n ¼ 1) and minimal (n ¼ 1)).
Tubular Basement Membrane
C4d deposits in the tubular basement membrane were seen in 48% of frozen biopsies, and could be further characterized as diffuse and focal in 10 and 38%, respectively. In contrast, only 4% of paraffinembedded biopsies showed staining for C4d and both biopsies in this category had only focal deposits. Thus, C4d staining score was significantly higher in frozen compared to paraffin-embedded biopsies (0.6±0.7 vs 0.04±0.2, Po0.001; Table 1 ). The mean tubular atrophy score (ct) was similar in biopsies with and without C4d deposits in the tubular basement membranes (1.8±0.9 vs 1.5±0.9, frozen samples; Table 4 ). The tubular atrophy score was also comparable in specimens with diffuse and focal staining pattern. One of the two paraffinembedded biopsies that had tubular basement membrane staining demonstrated BK virus nephropathy, and in this case, tubular basement membrane staining was accompanied by parietal Bowman's capsular epithelial basement membrane staining ( Figure 3 ).
Vascular Staining
Arterioles were seen in 40 frozen specimens and the C4d stain was interpreted as diffuse, focal and negative in 73, 5 and 22%, respectively. In 48 paraffin-embedded biopsies, the distribution of C4d was diffuse and focal in 40 and 31%, respectively, whereas the remaining 29% of biopsies were negative. The intensity of C4d staining was higher 
Arterioles (ah score)
FS, frozen section tissue; PE, paraffin-embedded tissue; TBM, tubular basement membrane; ct, tubular atrophy score; ah, arteriolar hyaline thickening score; cv, fibrous intimal thickening score. Scores presented as mean±s.d. (no. of biopsies).
All chronicity scores were assessed on paraffin-embedded sections only. Arterioles were identified in 40 cases of frozen vs 48 cases of paraffin-embedded biopsies, while arteries were available in 29 cases of frozen vs 44 cases of paraffin-embedded biopsies.
*P ¼ 0.04, (ah score in paraffin embedded biopsies, all positive vs negative), Mann-Whitney test. Significance of the distribution of C4d deposits I Batal et al in frozen than paraffin-embedded specimens (1.5 ± 0.9 vs 1.1 ± 0.8, P ¼ 0.028; Table 1 ). In paraffin-embedded specimens, biopsies with positive C4d staining showed higher arteriolar hyalinosis scores compared to negatively stained biopsies (1.3±0.9 vs 0.9±0.8, P ¼ 0.04; Table 4 ). This relationship was less obvious in frozen specimens (1.1 ± 1.0 all positively stained vs 0.6 ± 0.8 negatively stained, no significant difference; Table 4 ), possibly because frozen sections typically contained very small amounts of renal parenchyma with only one or two arterioles available for evaluation. Arteries were observed in 29 frozen and 44 paraffin-embedded specimens and showed a similar prevalence of C4d staining (65% frozen vs 50% paraffin embedded; Table 1 ). The staining pattern characterized as focal or diffuse was also similar in both specimen groups. Arterial staining appeared to be independent of the degree of arterial intimal thickening (cv score; Table 4 ).
Discussion
Several observations made during the course of this study call for comment. First, we found peritubular capillaries stain more often and more diffusely in frozen compared to paraffin-embedded tissue. However, in paraffin-embedded biopsies, if focal and diffuse staining patterns are combined, the association with circulating donor-specific antibodies is comparable to that attained by diffuse peritubular capillary staining in frozen biopsies. Before this work, three other studies have compared the relative sensitivity of C4d peritubular capillary staining using polyclonal antibodies on paraffin-embedded tissue and monoclonal antibodies on frozen tissue. Regele et al 17 found peritubular capillary C4d deposits in 5/12 (42%) biopsies using either method, and concluded that there was no difference in staining. Nadasdy et al 16 state that there was no difference in staining pattern between frozen and paraffin-embedded tissues. However, on perusal of their tabulated data, it becomes apparent that 4/17 biopsies that showed diffuse C4d on frozen tissue, gave only a focal reaction on paraffin-embedded tissue, whereas another biopsy showed complete loss of peritubular capillary staining. Seemayer et al 18 noted diffuse and focal C4d peritubular capillary staining in 40 and 36% of frozen vs 30 and 16% of paraffin-embedded samples, respectively, and concluded that C4d staining in frozen tissue is more sensitive than paraffin-embedded tissue. With regard to the association between C4d staining and detection of donor-specific antibodies, Nadasdy et al found that 9/14 (64%) of diffuse and 1/2 (50%) of focal staining in frozen biopsies were associated with donor-specific antibodies, whereas in paraffin-embedded biopsies, 7/10 (70%) diffuse and 2/5 (40%) focal staining reactions were associated with these antibodies. In our study, considering biopsies taken from patients with a history of donor-specific antibodies, diffuse, focal and negative peritubular capillary C4d staining patterns were seen in 11/14 (79%), 1/14 (7%) and 2/14 (14%) of frozen vs 5/14 (36%), 6/14 (43%) and 3/14 (21%) of paraffin-embedded biopsies. The absence of detectable circulating donor-specific antibodies in some patients with C4d-positive biopsies has been noted before, and even more frequently than observed by us. Thus, Worthington et al 13 found that 9/14 (64%) of their biopsies with diffuse peritubular capillary C4d staining and all their focally stained biopsies (100%) were not associated with circulating donorspecific antibodies. Similarly, Lederer et al 8 found that 11/25 (44%) of specimens with positive peritubular capillary C4d staining were not associated with donor-specific antibodies. Potential explanations include technical issues, different approaches for peritubular capillary C4d staining evaluation and scoring, complete absorbance of high affinity antibodies by allograft tissue 22 and non-HLA antibodies, which would not be detected during routine testing of donor-specific antibody. 24 In our study, the latter two possibilities are supported by the fact that diffuse C4d was associated with inferior outcome even in the absence of demonstrable donorspecific antibodies (three of six grafts lost). Indeed, in view of this unfavorable graft outcome, one could question whether the term 'false' positive is even appropriate for these cases.
According to some investigators, C4d deposits within glomerular basement membrane are observed in frozen but not paraffin-embedded specimens. In our laboratory, glomerular basement membrane staining is commonly found in paraffin-embedded biopsies. Regele et al 17 described glomerular basement membrane C4d stain in 12/12 of frozen but only 2/12 of paraffin-embedded biopsies. In another study, they demonstrated glomerular basement membrane staining in 6% of paraffin-embedded general kidney transplant biopsies and 12% of paraffin-embedded biopsies with chronic transplant glomerulopathy. 25 Sijpkens et al 19 found C4d depositions in glomerular capillaries to be both sensitive and specific for transplant glomerulopathy when they observed glomerular C4d deposits in 10/11 (91%) of biopsies with transplant glomerulopathy vs 2/13 (15%) of biopsies without transplant glomerulopathy. Conversely, Seemayer et al 18 found C4d staining to be a nonspecific indicator of glomerular capillary damage. However, no formal quantitation of cg was performed in their study. In our study, we found significant higher cg score in paraffin-embedded biopsies that were associated with positive glomerular basement membrane staining (P ¼ 0.03) as well as a trend toward a significant difference in frozen specimens with glomerular staining (P ¼ 0.1). In our opinion, glomerular basement membranes staining for C4d should not be regarded as specific for transplant glomerulopathy, as we have seen this finding in allograft kidneys with recurrent membranous nephropathy, membranoproliferative glomerulonephritis and anti-glomerular basement membrane nephritis (unpublished observation).
To the best of our knowledge, no previous study has compared tubular basement membrane staining in frozen and paraffin-embedded material. We found C4d tubular basement membrane staining primarily in frozen tissue, but do not understand the reason for this difference, although it may reflect the stability of the antigenic epitopes recognized by the antibodies used for immunohistochemistry. Seemayer et al 18 noted that tubular basement membrane staining for C4d localizes to areas of tubular atrophy, but, no formal quantization of ct score was performed in their study. In our biopsy material, tubular staining for C4d on frozen specimens did not correlate with the Banff score for tubular atrophy. Another pertinent study with respect to tubular basement membrane staining for C4d is that of Bracamonte et al, 20 who described granular tubular basement membrane immune deposits in 16/30 (53%) of patients showing BK virus nephropathy. In our material, tubular basement membrane staining for C4d could not be related to BK virus infection in frozen sections. However, one out of the two paraffin-embedded biopsies with this finding did, indeed, have viral nephropathy. Of interest, in this latter biopsy Bowman's capsular C4d staining was also observed. As BK virus can infect the Bowman's capsular epithelium, 26 one could speculate that this finding reflects virus-induced complement activation at this anatomic location.
Finally, we found arteriolar C4d to be more often diffuse and associated with a higher score in frozen compared to paraffin-embedded tissue (Table 1) . This may be due to an increase in sensitivity when staining is performed on frozen tissue. Arteriolar C4d deposition is also commonly found in liver, intestine and heart allografts and does not seem to correlate with a diagnosis of antibody-mediated rejection (unpublished observations). One could speculate that this represents complement activation following microvascular injury because of hypertension or calcineurin inhibitor toxicity. The fact that such injury does not occur in more proximal vessels might explain the lack of correlation between intimal thickening and C4d deposition in small-to medium-sized arteries.
